In cancer, one of the main barriers to effective chemotherapy is inefficient drug delivery. The
delivery of drugs to solid tumors involves various biochemical, biophysical, and mechanical …

Targeted drug delivery is emerging as a promising strategy to achieve better clinical
outcomes. Actively targeted drug delivery that utilizes overexpressed receptors or antigens …

Nitric oxide (NO) has a wide range of potential applications in tumor therapy. However, a
targeted delivery system for NO donors has remained elusive, creating a bottleneck that …

Antibodies possess properties that make them valuable as therapeutics, diagnostics, and
basic research tools. However, antibody chemical reactivity and covalent antigen binding …

Monoclonal antibodies (mAbs) directed against antigen-specific of multiple myeloma (MM)
cells have Fc-dependent immune effector mechanisms, such as complement-dependent …

Single-domain antibodies, derived from camelid heavy antibodies (nanobodies) or shark
variable new antigen receptors, have attracted increasing attention in recent years due to …

La enfermedad renal crónica (ERC), el cáncer y las enfermedades hematológicas
comparten áreas de influencia recíproca. El cáncer puede afectar al riñón bien como …

Immunotherapy has emerged as a promising cancer treatment option in recent years. In
immune “hot” tumors, characterized by abundant immune cell infiltration, immunotherapy …

Chronic kidney disease (CKD), cancer and hematological diseases share areas of
reciprocal influence. Cancer can affect the kidney either as glomerular lesions or as a result …

In order to develop new and effective medicines, pharmaceutical companies must be
modality agnostic. As science reveals an enhanced understanding of biological processes …